Matches in Nanopublications for { ?s ?p "[Antibody (Ab)-positive pure red-cell aplasia (PRCA) is a very rare but serious adverse event associated with recombinant human erythropoietin treatment (4.1 reports per 100,000 patient-years) in which patients produce antibodies to recombinant and endogenous erythropoietin, halting red blood cell production.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_assertion description "[Antibody (Ab)-positive pure red-cell aplasia (PRCA) is a very rare but serious adverse event associated with recombinant human erythropoietin treatment (4.1 reports per 100,000 patient-years) in which patients produce antibodies to recombinant and endogenous erythropoietin, halting red blood cell production.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_provenance.